## Abstract Breast cancer is a molecularly, biologically and clinically heterogeneous group of disorders. Understanding this diversity is essential to improving diagnosis and optimizing treatment. Both genetic and acquired epigenetic abnormalities participate in cancer, but the involvement of the e
DNA methylation profiling reveals a predominant immune component in breast cancers
✍ Scribed by Dedeurwaerder, Sarah (author);Desmedt, Christine (author);Calonne, Emilie (author);Singhal, Sandeep K. (author);Haibe-Kains, Benjamin (author);Defrance, Matthieu (author);Michiels, Stefan (author);Volkmar, Michael (author);Deplus, Rachel (author);Luciani, Judith (author);Lallemand, Françoise (author);Larsimont, Denis (author);Toussaint, Jérôme (author);Haussy, Sandy (author);Rothé, Françoise (author);Rouas, Ghizlane (author);Metzger, Otto (author);Majjaj, Samira (author);Saini, Kamal (author);Putmans, Pascale (author);Hames, Gérald (author);van Baren, Nicolas (author);Coulie, Pierre G. (author);Piccart, Martine (author);Sotiriou, Christos (author);Fuks, François (author)
- Book ID
- 102833710
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 843 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1757-4676
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES